Compound information
- Natural Products
- ZC1026913
- Molecular Formula
- C14H16Cl2N2O3S
- Molecular Weight
- 362.025868732 g/mol
- Structure
-
- IUPAC Name
- cyclopropyl-[4-(3,4-dichlorophenyl)sulfonylpiperazin-1-yl]methanone
- InChI
- InChI=1S/C14H16Cl2N2O3S/c15-12-4-3-11(9-13(12)16)22(20,21)18-7-5-17(6-8-18)14(19)10-1-2-10/h3-4,9-10H,1-2,5-8H2
- InChI Key
- IGDRKFDISYUVJD-UHFFFAOYSA-N
- SMILES
- O=C(C1CC1)N1CCN(S(=O)(=O)c2ccc(Cl)c(Cl)c2)CC1
- Source
- ZINC000013013235
Warheads
- Cyclopropane
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 22 | Ring Count | 3 |
Heteroatom Count | 8 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 57.69 Å2 | LogP | 2.502 |
LogS | -3.66 | LogD | 2.786 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.061 | Pgp substrate | 0.344 |
HIA | 0.97 | F20 % | 0.991 |
F30 % | 0.853 | Caco-2 | -4.411 |
MDCK | -4.915 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.995 | PPB | 99.697 |
VD | 1.197 | Fu | 1.007 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.114 | CYP1A2 substrate | 0.458 |
CYP2A6 substrate | 0.499 | CYP2B6 substrate | 0.66 |
CYP2C19 inhibitor | 0.91 | CYP2C19 substrate | 0.738 |
CYP2C8 substrate | 0.656 | CYP2C9 inhibitor | 0.364 |
CYP2C9 substrate | 0.996 | CYP2D6 inhibitor | 0.023 |
CYP2D6 substrate | 0.518 | CYP2E1 substrate | 0.234 |
CYP3A4 inhibitor | 0.7 | CYP3A4 substrate | 0.997 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.121 | CL | 5.326 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.841 | Hepatotoxicity | 0.997 |
Mutagenicity | 0.001 | Rat Oral Acute Toxicity | 0.253 |
FDAMDD | 0.772 | Skin Sensitization | 0.045 |
Carcinogenicity | 0.681 | Eye Corrosion | 0.011 |
Eye Irritation | 0.005 | Respiratory Toxicity | 0.315 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.386 | IGC50 | 4.031 |
LC50FM | -4.939 | LC50DM | 4.305 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.164 | NR-AR-LBD | 0.385 |
NR-AhR | 0.17 | NR-Aromatase | 0.66 |
NR-ER | 0.338 | NR-ER-LBD | 0.426 |
NR-PPAR-gamma | 0.168 | SR-ARE | 0.762 |
SR-ATAD5 | 0.305 | SR-HSE | 0.162 |
SR-MMP | 0.015 | SR-p53 | 0.042 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.